Findings show implantable cardioverter defibrillators preservation of arrhythmia shock function not impacted by MRI
The prospective cohort study of 626 patients with non-magnetic resonance imaging (MRI)-conditional implantable cardioverter defibrillators (ICDs) suggests said ICDs remain suitable to treat detected...
BioVentrix receives FDA expanded access program approval for ischemic heart failure treatment system
BioVentrix, a privately held medical device company focused on the development of less invasive therapies to directly treat the dilated left ventricle and reverse...
Digital cardiovascular care company tenacio launches US OptiCor AF patient management system
tenacio, a company focused on digitising cardiovascular care to improve patient outcomes and reduce healthcare costs, has announced its OptiCor patient management platform is...
Varian receives IDE for RADIATE-VT cardiac radioablation clinical trial
Varian, associated with Siemens Healthineers, announced today that the US Food and Drug Administration (FDA) approved an investigational device exemption (IDE) for the pivotal...
